| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 1.5.1.3 | drug development | the essential enzyme is a target for development of specific inhibitors | Nakaseomyces glabratus |
| EC Number | Crystallization (Comment) | Organism |
|---|---|---|
| 1.5.1.3 | purified recombinant enzyme, hanging drop vapor diffusion method, 13 mg/ml protein in 20 mM Tris pH 8.0, 20% glycerol, 0.1 mM EDTA and 2 mM DTT, incubation with 1.5 mM NADPH, mixing with an equal volume of crystallization solution containing 0.1 M Tris, pH 8.5, 35-40% PEG 4000 and 0.3-0.4 M MgCl2, X-ray diffraction structure determination and analysis at 1.95-2.11 A resolution | Nakaseomyces glabratus |
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.5.1.3 | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)-3-methylbut-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)-3-methylbut-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)pent-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)pent-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(2,6-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(2,6-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(2-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(2-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(3,5-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(3,5-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(4-methoxyphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(4-methoxyphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(4-tertbutylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(4-tertbutylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(6-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Homo sapiens | |
| 1.5.1.3 | 2,4-diamino-5-[3-(3-methoxy-5-(6-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 3-(2,4-diamino-6-methylpyrimidin-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol | - |
Homo sapiens | |
| 1.5.1.3 | 3-(2,4-diamino-6-methylpyrimidin-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 5-[3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | - |
Homo sapiens | |
| 1.5.1.3 | 5-[3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 5-[3-methoxy-3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | - |
Homo sapiens | |
| 1.5.1.3 | 5-[3-methoxy-3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine | - |
Homo sapiens | |
| 1.5.1.3 | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]pyrimidine-2,4-diamine | - |
Homo sapiens | |
| 1.5.1.3 | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]pyrimidine-2,4-diamine | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | additional information | inhibitor design, structure-activity relationships of the antifolates: methyl groups at the meta and para positions of the distal phenyl ring achieve the greatest number of interactions with the pathogenic enzyme and the greatest degree of selectivity over the human enzyme, antifungal activity can be tuned with substitution patterns at the propargyl and para-phenyl positions, overview | Nakaseomyces glabratus |
| EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.5.1.3 | 7,8-dihydrofolate + NADPH + H+ | Nakaseomyces glabratus | - |
5,6,7,8-tetrahydrofolate + NADP+ | - |
? | |
| 1.5.1.3 | 7,8-dihydrofolate + NADPH + H+ | Homo sapiens | - |
5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.5.1.3 | Homo sapiens | - |
- |
- |
| 1.5.1.3 | Nakaseomyces glabratus | Q6FPH0 | - |
- |
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.5.1.3 | 7,8-dihydrofolate + NADPH + H+ | - |
Nakaseomyces glabratus | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? | |
| 1.5.1.3 | 7,8-dihydrofolate + NADPH + H+ | - |
Homo sapiens | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 1.5.1.3 | DHFR | - |
Nakaseomyces glabratus |
| 1.5.1.3 | DHFR | - |
Homo sapiens |
| EC Number | Cofactor | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.5.1.3 | NADPH | - |
Nakaseomyces glabratus | |
| 1.5.1.3 | NADPH | - |
Homo sapiens |
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 1.5.1.3 | 0.00000055 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(2-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00000061 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(3,5-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0000055 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(2,6-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0000064 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(4-methoxyphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0000073 | - |
- |
Nakaseomyces glabratus | 5-[3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.0000073 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(6-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00001 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3-methoxy-5-(4-tertbutylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.000011 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)pent-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.000017 | - |
- |
Nakaseomyces glabratus | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]pyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.000025 | - |
- |
Nakaseomyces glabratus | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.000027 | - |
- |
Nakaseomyces glabratus | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)-3-methylbut-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00003 | - |
- |
Nakaseomyces glabratus | 5-[3-methoxy-3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.000039 | - |
- |
Nakaseomyces glabratus | 3-(2,4-diamino-6-methylpyrimidin-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol | |
| 1.5.1.3 | 0.00018 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(4-methoxyphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0002 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)-3-methylbut-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00021 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(4-tertbutylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00029 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3,4,5-trimethoxyphenyl)pent-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0004 | - |
- |
Homo sapiens | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]pyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.00075 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(2-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00122 | - |
- |
Homo sapiens | 5-[3-methoxy-3-(3,4,5-trimethoxyphenyl)prop-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.0013 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(2,6-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.00138 | - |
- |
Homo sapiens | 6-methyl-5-[3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.0014 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(3,5-dimethylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0014 | - |
- |
Homo sapiens | 2,4-diamino-5-[3-(3-methoxy-5-(6-methylphenyl)phenyl)but-1-ynyl]-6-methylpyrimidine | |
| 1.5.1.3 | 0.0017 | - |
- |
Homo sapiens | 5-[3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | |
| 1.5.1.3 | 0.00571 | - |
- |
Homo sapiens | 3-(2,4-diamino-6-methylpyrimidin-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-yn-1-ol |